SL Science Holding Limited Ordinary Shares (SLBT) - Total Liabilities
Based on the latest financial reports, SL Science Holding Limited Ordinary Shares (SLBT) has total liabilities worth $533.28K USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See SL Science Holding Limited Ordinary Shar liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
SL Science Holding Limited Ordinary Shares - Total Liabilities Trend (2023–2025)
This chart illustrates how SL Science Holding Limited Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of SL Science Holding Limited Ordinary Shar to measure how efficiently the company converts operating cash flow to free cash.
SL Science Holding Limited Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of SL Science Holding Limited Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Suzhou Delphi Laser Co. Ltd. A
SHG:688170
|
China | CN¥715.71 Million |
|
Shenzhen WOTE Advanced Materials Co Ltd
SHE:002886
|
China | CN¥1.83 Billion |
|
Ardelyx Inc
NASDAQ:ARDX
|
USA | $426.88 Million |
|
Zhongtong Bus Holding Co Ltd
SHE:000957
|
China | CN¥6.75 Billion |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥580.21 Million |
|
Great-Sun Foods Co Ltd
SHG:603336
|
China | CN¥341.42 Million |
|
Tipco Asphalt Public Company Limited
BK:TASCO
|
Thailand | ฿9.58 Billion |
|
AnShan Heavy Duty Mining Machinery Co Ltd
SHE:002667
|
China | CN¥2.17 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down SL Science Holding Limited Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SLBT asset base.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SL Science Holding Limited Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SL Science Holding Limited Ordinary Shares (2023–2025)
The table below shows the annual total liabilities of SL Science Holding Limited Ordinary Shares from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $533.28K | +160.26% |
| 2024-12-31 | $204.90K | -69.33% |
| 2023-12-31 | $668.07K | -- |
About SL Science Holding Limited Ordinary Shares
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was for… Read more